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Kei Yoshitome and Takemi Otsuki
Abstract
Mesothelioma is the most serious of the asbestos-related diseases. It is caused 
by exposure to relatively low doses of asbestos and takes a long period to develop, 
which suggests the enactment of gradual adverse effects other than cellular toxicity. 
The immune system, which can play a role in tumor prevention, is a presumable tar-
get of asbestos by accumulation in lymph nodes and then slowly affecting functions 
of immune cells. Here, we describe key findings obtained from our studies concern-
ing the immune-suppressive effects of asbestos and functional alteration in immune 
cells of patients with mesothelioma as well as plaque-positive subjects. Asbestos 
exposure of cell cultures resulted in decreased natural and acquired cytotoxicity 
exerted by NK cells and CTLs and the ability of Th1 cells to activate and support 
antitumor immunity. In contrast, asbestos exposure augmented Treg cell function 
and generation of fibrogenic/suppressive macrophages. Mesothelioma patients also 
showed similar characteristics in certain alterations caused by asbestos exposure. 
Additionally, our recent study established immunological screening devices for 
mesothelioma and asbestos exposure on the basis of comprehensive analysis of 
peripheral blood. Those findings underscore the importance of the immunological 
effects of asbestos and should assist further understanding of the mechanism and 
early detection of mesothelioma.
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1.  Introduction: immune system as a key player in malignant 
mesothelioma following exposure to asbestos
Although asbestos has been banned in many European countries and the USA, 
as well as Japan, it continues to be used globally, and a report in 2018 by the WHO 
estimated that about 125 million people in the world continue to be exposed 
to asbestos at the workplace [1]. Occupational exposure to asbestos causes the 
death of at least 107,000 people from lung cancer, malignant mesothelioma, and 
pneumoconiosis (asbestosis) every year. Additionally, countries where asbestos 
remains have an increasing number of newly exposed individuals, especially 
during activities related to the destruction of old houses and buildings made of 
materials including some kinds of asbestos. That type of exposure to asbestos can 
occur in a variety of contexts such as the illegal destruction of asbestos-containing 
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structures, the aftermath of natural disasters such as earthquakes and tsunamis, 
or even terrorism. It is known that the terrorist attacks in New York City on 
September 11, 2001, released 2000 tons of asbestos fibers into the air, subjecting 
an estimated 410,000 people to those fibers, including first responders, nearby 
residents, and workers in charge with cleaning up [2]. In the case of malignant 
mesothelioma, a poor prognostic disease specifically caused by the inhalation of 
asbestos, the disease develops silently and suddenly after about 40 years following 
the initial commencement of asbestos exposure, which means that deaths from 
malignant mesothelioma are increasing or achieving a peak in asbestos-banned 
countries. It has been estimated by Murayama T. that those deaths in Japan will 
peak around the year 2030 [3].
Thus, malignant mesothelioma is a global issue that needs to be solved. 
However, the following characteristics of mesothelioma make early diagnosis dif-
ficult to achieve. Malignant mesothelioma does not follow a dose-dependent rule 
in terms of toxicology but rather develops in people exposed to asbestos at low 
or middle doses of concentration [4]. Additionally, as mentioned above, it takes 
about 40 years to develop it. Therefore, sometimes people are suddenly informed 
that they have malignant mesothelioma, even though they do not remember any 
exposure to asbestos in their history, thereby leading to a delay in diagnosis. In 
the context of these characteristics of the relationship between asbestos exposure 
and malignant mesothelioma, we arrived at one possibility: alterations in immune 
functions might connect asbestos exposure to malignant mesothelioma. It is true 
that asbestos fibers cause cellular toxicity, mutagenicity, and the production of 
reactive oxygen species (ROS). Oxidized pyrimidine and alkalized nucleic acid 
base components correlate with the time of asbestos exposure, and the mutation 
frequency of lung DNA increased following intratracheal instillation of rats with 
asbestos [5–9]. Those findings indicate that asbestos fibers have the potential to 
cause transformation of healthy mesothelial cells. However, the body is equipped 
with an immune system, which can detect and remove those abnormal cells 
transiently arising due to certain kinds of toxic effects. Therefore, it is reason-
able to assume that the immune system plays a role in protecting the body from 
malignant mesothelioma following exposure to asbestos and that the immune 
system must be subject to some kind of impairment prior to the development 
of mesothelioma. In fact, inhaled particles and fibers reach draining lymph 
nodes, and it has been reported that people exposed to asbestos occupationally or 
nonoccupationally showed accumulation of asbestos fibers in their lymph nodes 
[10, 11]. It is possible for asbestos to accumulate in the body slowly at low doses 
of exposure, thus subjecting immune cells to chronic asbestos exposure. Those 
cells circulate through the peripheral blood which might then result in a sup-
pressed immune system. Moreover, if some alterations in the immune system are 
observed upon exposure to asbestos as well as in patients with malignant meso-
thelioma, we might utilize those changes to establish immunology-based screen-
ing devices to assist in the early detection of malignant mesothelioma as well as in 
cases of general asbestos exposure. Thus, we believe that the immune system is a 
key player in the mechanism involving asbestos-induced malignant mesothelioma 
and therefore a prime target for the development of screening methodologies. 
Consequently, we have been investigating the immunological effects of asbestos 
exposure and immunological alterations in patients with malignant mesothelioma 
and in people exposed to asbestos using multiple analyses of peripheral blood. 
Here we present the results of our investigations in this field and finally propose 
immunological screening devices for the detection of mesothelioma and asbestos 
exposure.
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2.  TGF-beta production by macrophages is crucial for suppressed 
antitumor immunity/tumor progression as well as lung fibrosis 
following asbestos exposure
Macrophages are the first population of immune cells which interact with inhaled 
asbestos in the body. It is well-known that alveolar macrophages (AMs) play a role in 
inflammation following inhalation of asbestos, where AM-mediated activities include 
the generation of reactive oxygen species (ROS), reactive nitrogen species (RNS), 
and inflammatory cytokines such as TNF-α [12–16]. Those inflammatory responses 
continue chronically since inhaled asbestos accumulates in the lungs, which induces 
overproduction of the extracellular matrix (ECM) and leads to asbestos-induced 
lung fibrosis, known as asbestosis [6, 17]. TNF-α chronically produced by AMs is a 
key phenomenon upstream of fibrosis because it induces production of transform-
ing growth factor-beta (TGF-β) by fibroblasts and other cells, which in turn induces 
production of ECM. In fact, it has been reported that TNF-α-deficient mice showed 
decreased TGF-β as well as ECM following exposure to asbestos [17, 18]. Additionally, 
we also demonstrated in a previous study that the macrophage cell lines of RAW264.7 
and J774 showed production of O2
− and NO2
− upon exposure to asbestos [14].
Thus, it is not unexpected that AMs have received attention given their role in 
inflammatory responses upon exposure to asbestos. However, we decided to focus 
on the fact that AMs also have the potential to produce TGF-β and that AMs can 
migrate away from the local site with chronic inflammation to other areas, where 
they are able to exert their effect in the absence of asbestos, which is more crucial 
for the induction of fibrogenic responses than simple production of TGF-β only at 
inflammatory sites. First, we noted that high doses of asbestos caused apoptosis of 
AMs during culture, while low doses failed to do so but did induce production of 
TGF-β. Therefore, we compared the ex vivo production of TGF-β by AMs from rats 
instilled with asbestos via the trachea with the in vitro production of TGF-β by AMs 
during culture upon exposure to asbestos. AMs collected at 5 days after instillation 
of rats with asbestos showed significantly higher amounts of TGF-β production in 
the culture for 5 days than AMs collected from control rats. However, it was surpris-
ing that AMs collected from control rats showed the same amount of TGF-β in the 
5-day culture as AMs collected from rats exposed to asbestos in vivo. Moreover, 
AMs came to produce much greater amounts of TGF-β during continuous culture in 
fresh medium, and these viable AMs upon exposure to asbestos showed increased 
intracellular expression of Bcl-2, the product of a representative anti-apoptotic 
gene [19]. Those findings indicate that asbestos-exposed AMs can acquire the 
ability to produce high amounts of TGF-β in the absence of other cell types and 
with long survival supported by an anti-apoptotic gene, which might contribute 
to the progression of lung fibrosis following exposure to asbestos. That study was 
originally performed from the viewpoint of investigating the fibrogenic role of AMs 
as mentioned above. However, we believe that this functional alteration in AMs 
upon exposure to asbestos can be meaningfully interpreted as antitumor immunity 
upon exposure to asbestos. TGF-β is a representative cytokine that functions to 
suppress cell proliferation and survival of immune cells, natural killer (NK) cell 
function, and generation of cytotoxic T lymphocytes (CTLs) specific for tumors, as 
well as function in the induction of regulatory T cells [20–28]. TGF-β is produced by 
lymphoid cells as well as myeloid lineage cells, and those myeloid-derived suppres-
sor cells play a role in angiogenesis which leads to tumor promotion [29]. Taken 
together, our findings underscore the significance of TGF-β production by macro-
phages which is crucial for suppressed antitumor immunity and tumor progression 
as well as lung fibrosis following asbestos exposure.
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3.  Impaired cytotoxicity of NK cells with altered expression of activating 
receptors caused by asbestos related with mesothelioma
NK cells represent one population of cells involved in innate immunity and 
play a role in tumor-surveillance as a first line of defense. One previous study 
has reported that people with low natural cytotoxic activity of peripheral blood 
lymphocytes showed higher cumulative incidence rates of cancer diseases than 
people with high activity in both men and women [30]. This highlights the impor-
tance of NK cell function in the prevention of tumor diseases including malignant 
mesothelioma following asbestos exposure. NK cells have a different machinery 
to recognize target cells compared with T lymphocytes. NK cells equip activating 
and inhibitory receptors against ligands expressed on the cell surface of targets, 
thereby determining whether or not to attack targets [31–37]. Finally, activating 
receptors engage in signal transduction to degranulate cytotoxic granules, includ-
ing perforin and granzymes, which cause apoptosis of target cells [38]. Therefore, 
we focused on the effect of asbestos exposure on the expression of receptors on 
NK cells. First, we commenced continuous exposure of human NK cell line YT-A1 
culture to asbestos. Following 1 month of culture, YT-A1 cells did not show any 
alterations in natural cytotoxic activity as measured by incubation with K562 cells. 
However, cells showed marked decreases in cytotoxicity after 4–5 months of culture 
with asbestos. It was also found that intracellular levels of granzyme A and perforin 
decreased in cells cultured with asbestos at the same time, but granzyme B did not 
decrease [39]. Furthermore, YT-A1 cells continuously exposed to asbestos (YT-CB5) 
showed decreases in cell surface expression of activating receptors NKG2D and 
2B4 but did not show any alterations in the expression of NKG2A or CD94, which 
form a heterodimer that functions as an inhibitory receptor. NKG2D and NKG2A 
are members of the NKG2 family, members of which contain a lectin-like domain, 
whereas 2B4 (CD244) is a representative member of the signaling lymphocytic 
activation molecule (SLAM) family expressed on NK cells [32, 34]. Since NKG2D 
is known to contribute to natural cytotoxicity against K562 cells [40], it is reason-
able to suggest that decreased cytotoxicity of YT-CB5 can be attributed to low 
expression of NKG2D. Signals from many activating receptors are mediated by 
extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) 
to effect degranulation [40]. In fact, it was found that YT-CB5 showed decreases 
in degranulation as well as phosphorylation of ERK1/2 following stimulation with 
antibodies to NKG2D [41]. 2B4 can receive stimulation with CD48 as ligand or 
anti-2B4 antibody to generate a signal that leads to cytotoxicity [35–37]. As 2B4 
is not involved in the cytotoxicity of K562 cells, we utilized P815 cells bound to 
anti-2B4 antibody as targets to measure cytotoxicity with 2B4 receptor. It was 
found that YT-CB5 showed decreases in cytotoxicity against those P815 cells and in 
the degranulation induced by plate-coated antibodies to 2B4 [39]. Those findings 
indicate that asbestos exposure causes impaired cytotoxicity of NK cells attributable 
to alterations in cell surface expression of activating receptors. Moreover, we also 
examined the effect of asbestos exposure on NK cells using human peripheral blood 
mononuclear cells (PBMCs). Unlike the result obtained from cultures of YT-A1, 
NK cells in PBMC culture upon exposure to asbestos showed clear decreases in cell 
surface expression of NKp46 but not in NKG2D or 2B4 compared with grass wool 
representative man-made mineral fiber. NKp46 is a member of the natural cytotox-
icity receptor (NCR) family, and it is known that the density of NKp46 is correlated 
with cytotoxicity against K562 cells [32–34]. Finally, we examined the natural 
cytotoxicity and expression of activating receptors of NK cells in PBMCs prepared 
from healthy volunteers and patients with malignant mesothelioma. Interestingly, 
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NK cells of mesothelioma patients showed low natural cytotoxicity as well as low 
expression of NKp46, but not of NKG2D or 2B4 in a similar manner to NK cells in 
PBMC culture exposed to asbestos. Taken together, our investigations of NK cell 
functions indicate that exposure to asbestos has the potential to decrease expression 
of activating receptors on NK cells, where NKp46 is a representative target for the 
effects of asbestos exposure, in addition to the NK cells of patients with malignant 
mesothelioma.
4.  Decrease in Th1 phenotype caused by asbestos exposure and shown in 
mesothelioma patients more strongly than plaque-positive subjects
In an effort to examine the effect of asbestos exposure on CD4+ T lymphocytes, 
our study utilized the human polyclonal T-cell line MT-2 [42, 43], and cells were 
cultured with continuous exposure to asbestos. From those cultures we obtained 
six asbestos-exposed sublines (MT-2CA1-3, MT-2CB1-3) and the original control 
MT-2 cell line (MT-2Org). Those cell lines were subjected to DNA microarray assays 
followed by clustering analyses. From the results, it was found that expression of 
84 genes increased and 55 genes decreased by ca. twofold in the asbestos-exposed 
sublines and that all of the asbestos-exposed cell lines showed similar gene expres-
sion patterns [44]. Pathway and network analysis using the MetaCore System 
clarified that the Top 30 pathway results included the IFN-γ signaling pathway. 
Additionally, our previous study also identified decreases in IFN-γ production by 
MT-2CB1 cells [45]. In fact, the asbestos-exposed sublines showed decreases in 
expression of IFN regulatory factor 9 (IRF9) and IFN-stimulated gene factor-3 
(ISGF3) as well as a chemokine receptor of CXCR3, which is positively regulated by 
IRF9. Th1 cells induced by stimulation are known to show increases in IFN-γ pro-
duction and CXCR3 expression, which contribute to antitumor immune function 
[46, 47]. Flow cytometric analyses and real-time PCR (RT-PCR) confirmed that 
the percentage of cells positive for CXCR3 and mRNA levels of CXCR3 decreased in 
asbestos-exposed sublines, whereas that of CCR5, another chemokine receptor of 
the Th1-type, remained unchanged [44]. Moreover, CD4+ T lymphocytes prepared 
from PBMCs were cultured in a similar manner upon exposure to asbestos. First, 
freshly purified CD4+ T cells were expanded by stimulation with CD3 and CD28 
to obtain sufficient cell numbers, and then those cells were utilized for culture in 
media supplemented with IL-2 upon exposure to asbestos. After 7 days of culture, 
there was no difference in %CXCR3+ cells between cultures with and without 
asbestos exposure, although the percentage of those cells decreased 28 days later, 
in contrast to no changes being observed in %CCR5+ cells. Additionally, asbestos-
exposed CD4+ T cells also showed decreases in intracellular expression of IFN-γ. 
Those findings are consistent with the results obtained from the experiment with 
MT-2 and indicate that asbestos exposure has the potential to effect a decrease 
in Th1 cell function of human primary T helper cells [48]. Finally, PBMCs from 
patients with malignant mesothelioma and subjects positive for pleural plaque, a 
representative sign of asbestos inhalation [5], were analyzed in a manner similar 
to the in vitro experiments mentioned above. Compared with healthy volunteers, 
both mesothelioma and plaque-positive groups showed low %CD4+CXCR3+ cell 
numbers in PBMCs and were much lower in the mesothelioma than in the plaque-
positive group, whereas %CD4+CCR5+ numbers did not differ among the groups. 
Additionally, the mesothelioma group (but not the plaque-positive group) showed 
lower IFN-γ mRNA levels in CD4+ T cells compared with healthy people [48]. Taken 
together, the results obtained from our studies demonstrate that asbestos exposure 
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causes decreases in the Th1 phenotype of CD4+ T cells, which is shown in patients 
with malignant mesothelioma more strongly than in plaque-positive subjects.
5.  Augmented Treg function mediated through cell–cell interaction and 
suppressive cytokines caused by exposure to asbestos
Treg cells represent a key population of cells with the phenotype 
CD4+CD25+Foxp3+ and function to suppress excess activation of immune 
responses as well as allow tumor cells to escape from immune surveillance  
[49, 50]. It has been reported that MT-2 cells also show this phenotype of cell sur-
face markers and Treg-like suppressive function [51–54]. Additionally, MT-2 is a 
human polyclonal T-cell line immortalized by human T-cell leukemia virus type-1 
(HTLV-1) and infection which causes adult T-cell leukemia (ATL) [42, 43]. Most 
CD4+CD25+ ATL cells express Foxp3, and some ATL cells have Treg-like suppres-
sive function [51, 52, 54–56]. As a result, it has been suggested that ATL cells are 
derived from Treg cells. Therefore, MT-2 is useful in examining Treg cell function 
as well as Th cell function. Accordingly, we examined the Treg cell function of the 
MT-2 cell line continuously exposed to asbestos in the same manner as described 
above. First, we determined that the production of IL-10 increased twofold in the 
cell line exposed to asbestos relative to the original cell line, while the production 
of IFN-γ, TNF-α, and IL-6 decreased. IL-10 and TGF-β are immune-suppressive 
cytokines produced by Treg cells [26]. To examine phenomena upstream of the 
increase in IL-10 production, cells were treated with PP2, a specific inhibitor of 
Src family kinases (SFKs) which positively control IL-10 through transcription 
factors [57–59]. PP2 suppressed IL-10 mRNA levels, resulting in no difference 
between asbestos-exposed and nonexposed MT-2 sublines. Additionally, the 
subline exposed to asbestos showed increased Bcl-2 mRNA levels and a decrease 
in Bax, consistent with the fact that those cells survived in the toxic environ-
ment induced by exposure to asbestos. In fact, bcl-2 siRNA caused a decrease in 
cell growth upon exposure to asbestos. Moreover, phosphorylation of STAT3, 
part of the signaling pathway downstream of stimulation with IL-10 and target 
transcription of the bcl-2 gene, increased in the MT-2 subline exposed to asbestos 
[45]. Those findings indicate that asbestos induced an SFK-mediated increase in 
production of IL-10, in other words increased “Treg function,” with increased sur-
vival ability attributed to high bcl-2 expression through the STAT pathway down-
stream of IL-10 in an autocrine manner. Furthermore, MT-2 subline exposed to 
asbestos was analyzed for Treg function in terms of suppressing the proliferation 
of CD4+CD25− responder T (Tresp) cells, to express GITR and CTLA-4 cell surface 
markers and to produce suppressive cytokines such as TGF-β as well as IL-10. The 
asbestos-exposed subline showed enhanced suppression of Tresp cell proliferation 
stimulated with anti-CD3 antibody and induced dendritic cells (DCs), whereas 
there were no differences in cell proliferation stimulated with anti-CD3 and 
anti-CD28 antibodies between the sublines, suggesting the importance of cell–cell 
interactions for the enhanced suppression. Consistent with those findings, it was 
found that MT-2 subline exposed to asbestos tended to have decreased cell surface 
CTLA-4, which exerts suppressive function by cell–cell interactions with CD80 or 
CD86 on DCs [60, 61]. Additionally, TGF-β was produced at high concentrations 
by MT-2 subline exposed to asbestos, as IL-10 was also produced. It is interesting 
that the inhibited production of IL-10 or TGF-β by shRNA for those cytokine 
genes decreased the suppression efficiency of Tresp cell proliferation in the culture 
with transwell, indicating the absence of cell–cell interactions. Taken together, our 
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results indicate that exposure to asbestos causes augmentation of Treg function 
mediated through cell–cell interactions as well as the production of suppressive 
cytokines.
6.  Interfered induction and maintenance of cytotoxic T lymphocyte 
activity caused by asbestos and shown in mesothelioma, but not 
plaque-positive, subjects
CD8+ cytotoxic T lymphocytes (CTLs) play a crucial role in antitumor immu-
nity where they function to attack tumor cells together with NK cells [62]. Both 
NK cells and CTLs utilize perforin and granzymes to attack targets [63]. However, 
in contrast to NK cells, CTLs need to be induced from naïve CD8+ T cells by 
stimulation with antigen for activation, which occurs upon interaction with DCs 
as well as CD4+ T lymphocytes in lymph nodes [64–67], where inhaled asbestos 
fibers accumulate as mentioned above. Therefore, we sought to examine the effect 
of asbestos exposure on the induction phase of functional CTLs following stimu-
lation with antigen. The mixed lymphocyte reaction (MLR) is an experimental 
and useful method to induce cell-mediated immunity by culturing two kinds of 
whole immune cells that differ allogenically from each other, such as CD8+ T as 
well as CD4+ T cells and DCs. Therefore, we employed MLR by culturing PBMCs 
as responder with allogenically different and irradiated PBMCs as stimulator upon 
exposure to asbestos in an effort to examine a variety of characteristics such as 
cell proliferation, cytotoxicity for allogenic target cells, and cytokine production 
by CD8+ T cells. Asbestos exposure during culture for MLR caused suppressed 
cytotoxic activity of CTLs with decreased proliferation of CD8+ T cells and 
production of IFN-γ and TNF-α, representative cytokines produced by activated 
CTLs [68]. Additionally, those CTLs harvested from culture with asbestos showed 
decreases in CD25 and CD45RO and an increase in CD45RA, which are activated 
and antigen-encountered markers and naïve markers on the cell surface, respec-
tively [69]. Moreover, it is possible that prolonged exposure to asbestos might 
affect the functional activity of CTLs following antigen stimulation. EBT-8 is a 
cell line established from large granular lymphocyte leukemia of T-cell origin and 
shows surface expression of CD2, CD3, CD8, HLA-DR, and T-cell receptor alpha/
beta, which are characteristic of cytotoxic T lymphocytes. Therefore, we exam-
ined alterations in the function of EBT-8 cells continuously exposed to asbestos 
for greater than 1 month. EBT-8 cells exposed to asbestos showed decreases 
in the percentage of cells positive for intracellular perforin, but not granzyme 
B. Additionally, those cells showed significantly decreased production of IFN-γ 
following stimulation with anti-CD3 antibody compared with control cells [70]. 
Those findings indicate that asbestos exposure interfered with the induction of 
functional CTLs following stimulation with antigen and that prolonged exposure 
to asbestos disrupts the functionality of CTLs, thereby leading to decreases in 
cytotoxic potential as well as production of IFN-γ. Along with those studies, we 
examined the functionality of CD8+ T cells in peripheral blood of patients with 
malignant mesothelioma and pleural plaque-positive subjects. Mesothelioma 
patients showed decreases in the percentage of stimulation-induced intracellular 
perforin+, but not granzyme+, cells in CD8+ T cells compared with healthy people, 
whereas plaque-positive subjects did not show any decrease [71]. Taken together, 
our results indicate that asbestos exposure interferes with induction and main-
tenance of functional CTLs, similar to peripheral CD8+ T cells of mesothelioma 
patients.
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7. Conclusion
Thus, our studies clarified a number of characteristics pertaining to asbestos-
induced immunological impairment in acquired immunity as well as in innate 
immunity, some of which were also actually observed in patients with malignant 
mesothelioma. Figure 1 summarizes those immune-suppressive effects of asbestos 
which presumably contribute to the development of malignant mesothelioma. 
Asbestos exposure suppressed immune-activating functions (Th1) and natural 
(NK) and acquired cytotoxicity (CTLs), whereas asbestos augmented functions 
of suppressive T lymphocytes (Tregs). Additionally, high production of TGF-β by 
long-surviving macrophages (Mϕ) caused by asbestos contributes to lung fibrosis 
as well as immune suppression. The immunological conditions generated by those 
characteristics allow abnormal cells caused by cellular toxicity of asbestos to escape 
from immune surveillance and survive to develop malignant mesothelioma. As 
mentioned above, it is actual that some of the characteristics caused by asbestos 
exposure were also shown in patients with malignant mesothelioma. Interestingly, 
plaque-positive subjects (without tumors) showed no impairment in some func-
tions compared with mesothelioma patients, suggesting that their sustained 
immune functions protected them from malignant mesothelioma following 
asbestos exposure. On the basis of our present knowledge, we recently undertook 
a comprehensive analysis of the immunological characteristics of peripheral 
blood of mesothelioma patients as well as plaque-positive subjects. Parameters 
examined included cell surface markers, mRNA expression, and plasma cytokine 
concentrations. From the results of these analyses, we established three formulae 
for scoring mesothelioma, pleural plaque without tumors, and asbestos exposure 
(for both mesothelioma patients and plaque-positive subjects) (international patent 
Figure 1. 
Summarized illustration of the findings concerning a suppressed immune system caused by exposure to asbestos 
obtained from our studies. It was found that asbestos exposure showed immunological effects on various kinds 
of cells (purple arrows). Asbestos exposure during culture caused decreases in natural and acquired cytotoxicity 
and Th1 function associated with decreases in expression of NKp46, perforin, IFN-γ, TNF-α, and CXCR3 
(colored red). In contrast, asbestos exposure caused increases in Treg function as well as fibrogenic/suppressive 
macrophages associated with increases in expression of CTLA-4, TGF-β, and IL-10 (colored blue). Those 
suppressed immune functions presumably allow abnormal mesothelial cells, arising from healthy cells caused by 
toxicity of asbestos, to escape from immune surveillance and survive to develop into malignant mesothelioma.
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pending). The immunological screening devices might contribute to the detection 
of subgroups of people who have suppressed immune functions among people 
exposed to asbestos prior to diagnosis by CT images and histological observations. 
Moreover, those of our knowledge encourage us to treat mesothelioma with some 
kinds of immunotherapy. It is reasonable to assume that inhibitors targeting on 
Treg cells or suppressive macrophages might contribute to treatment of malignant 
mesothelioma. In addition, it has also been found that asbestos-caused decrease 
in cytotoxicity of CTL was improved by exogenous IL-2, but not accompanied 
with restoration of cell surface markers [72], which suggests that an appropriate 
immunotherapy might be developed to augment antitumor immunity in patients 
with mesothelioma as well as subjects exposed to asbestos. Thus, our studies could 
further our understanding of the immunological mechanisms associated with 
asbestos-induced malignant mesothelioma and perhaps facilitate the development 
of methodologies that can be employed for the early detection as well as treatment 
of mesothelioma. These are issues we intend to further address in the future.
Acknowledgements
The authors thank Ms. Tamayo Hatayama, Shoko Yamamoto, Miho Ikeda, and 
Ayasa Kamezaki for their technical assistance. Grant support from JPSS KAKENHI 
Grants (17790375, 18790386, 18390186, 19790411, 19790431, 20890270, 20390178, 
22700933, 22790550, 23790679, 24590770, 25860470, 16 K09114, 16H05264, and 
19H03892) and Kawasaki Medical School Project Grant (17-210S, 17-404 M, 18-209 T, 
18-403, 19-205Y, 19-407 M, 20-210O, 20-411I, 21-107, 21-201, 21-401, 22-A29, 23B66, 
23P3, and 28B051) is gratefully acknowledged.
Conflict of interest
The authors declare that there is no conflict of interest regarding the publication 
of this paper.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
10
Asbestos-Related Diseases
[1] WHO. Asbestos: elimination 
of asbestos-related diseases; 2018. 
Available from: http://www.who.int/
news-room/fact-sheets/detail/asbestos-
elimination-of-asbestos-related-diseases
[2] King D. Asbestos, 9/11 and the 
World Trade Center; 2019. Available 
from: https://www.asbestos.com/
world-trade-center/
[3] Murayama T, Takahashi K, Natori Y, 
Kurumatani N. Estimation of future 
mortality from pleural malignant 
mesothelioma in Japan based on an 
age-cohort model. American Journal of 
Industrial Medicine. 2006;49(1):1-7
[4] Bohlig H, Otto H. Asbest unt 
Mesotheliom : Fakten, Fragen, 
Umweltprobleme. Stuttgart: G. Thieme; 
1975
[5] Sporn TA, Roggli VL.  
Mesothelioma. In: Roggli VL, Oury TD,  
Sporn TA, editors. Pathology of 
Asbestos-Associated Diseases. 3 Ed. 
New York: Springer-Verlag Berlin 
Heidelberg; 2014. pp. 81-140
[6] Mossman BT, Churg A. Mechanisms 
in the pathogenesis of asbestosis 
and silicosis. American Journal of 
Respiratory and Critical Care Medicine. 
1998;157(5 Pt 1):1666-1680
[7] Mossman BT, Kamp DW,  
Weitzman SA. Mechanisms of 
carcinogenesis and clinical features of 
asbestos-associated cancers. Cancer 
Investigation. 1996;14(5):466-480
[8] Dusinska M, Collins A,  
Kazimirova A, Barancokova M, 
Harrington V, Volkovova K, et al. 
Genotoxic effects of asbestos 
in humans. Mutation Research. 
2004;553(1-2):91-102
[9] Topinka J, Loli P, Georgiadis P,  
Dusinska M, Hurbankova M, 
Kovacikova Z, et al. Mutagenesis by 
asbestos in the lung of lambda-lacI 
transgenic rats. Mutation Research. 
2004;553(1-2):67-78
[10] Dodson RF, Huang J, Bruce JR. 
Asbestos content in the lymph nodes of 
nonoccupationally exposed individuals. 
American Journal of Industrial 
Medicine. 2000;37(2):169-174
[11] Dodson RF, Williams MG Jr, 
Corn CJ, Brollo A, Bianchi C. A 
comparison of asbestos burden in lung 
parenchyma, lymph nodes, and plaques. 
Annals of the New York Academy of 
Sciences. 1991;643:53-60
[12] Kamp DW, Graceffa P, Pryor WA, 
Weitzman SA. The role of free radicals 
in asbestos-induced diseases. 
Free Radical Biology & Medicine. 
1992;12(4):293-315
[13] Iguchi H, Kojo S, Ikeda M. Nitric 
oxide (NO) synthase activity in the 
lung and NO synthesis in alveolar 
macrophages of rats increased on 
exposure to asbestos. Journal of Applied 
Toxicology: JAT. 1996;16(4):309-315
[14] Nishiike T, Nishimura Y, Wada Y, 
Iguchi H. Production of nitric oxide 
elevates nitrosothiol formation resulting 
in decreased glutathione in macrophages 
exposed to asbestos or asbestos 
substitutes. Archives of Toxicology. 
2005;79(2):83-89
[15] Dubois CM, Bissonnette E, 
Rola-Pleszczynski M. Asbestos fibers 
and silica particles stimulate rat 
alveolar macrophages to release tumor 
necrosis factor. Autoregulatory role 
of leukotriene B4. The American 
Review of Respiratory Disease. 
1989;139(5):1257-1264
[16] Li XY, Lamb D, Donaldson K. The 
production of TNF-alpha and IL-1-like 
activity by bronchoalveolar leucocytes 
References
11
Suppressed Immune System Caused by Exposure to Asbestos and Malignant Mesothelioma
DOI: http://dx.doi.org/10.5772/intechopen.90763
after intratracheal instillation of 
crocidolite asbestos. International 
Journal of Experimental Pathology. 
1993;74(4):403-410
[17] Liu JY, Brody AR. Increased TGF-
beta1 in the lungs of asbestos-exposed 
rats and mice: Reduced expression in 
TNF-alpha receptor knockout mice. 
Journal of Environmental Pathology, 
Toxicology and Oncology: official 
organ of the International Society for 
Environmental Toxicology and Cancer. 
2001;20(2):97-108
[18] Liu JY, Brass DM, Hoyle GW,  
Brody AR. TNF-alpha receptor 
knockout mice are protected from the 
fibroproliferative effects of inhaled 
asbestos fibers. The American Journal of 
Pathology. 1998;153(6):1839-1847
[19] Nishimura Y, Nishiike-Wada T,  
Wada Y, Miura Y, Otsuki T, Iguchi H. 
Long-lasting production of TGF-beta1 
by alveolar macrophages exposed 
to low doses of asbestos without 
apoptosis. International Journal of 
Immunopathology and Pharmacology. 
2007;20(4):661-671
[20] Ghiringhelli F, Menard C, Terme M, 
Flament C, Taieb J, Chaput N, et al. 
CD4+CD25+ regulatory T cells 
inhibit natural killer cell functions 
in a transforming growth factor-
beta-dependent manner. The 
Journal of Experimental Medicine. 
2005;202(8):1075-1085
[21] Gorelik L, Flavell RA. Immune-
mediated eradication of tumors through 
the blockade of transforming growth 
factor-beta signaling in T cells. Nature 
Medicine. 2001;7(10):1118-1122
[22] Gorelik L, Flavell RA. Transforming 
growth factor-beta in T-cell biology. 
Nature Reviews. Immunology. 
2002;2(1):46-53
[23] Li MO, Flavell RA. TGF-beta: 
A master of all T cell trades. Cell. 
2008;134(3):392-404
[24] Li MO, Wan YY, Sanjabi S,  
Robertson AK, Flavell RA. 
Transforming growth factor-beta 
regulation of immune responses. 
Annual Review of Immunology. 
2006;24:99-146
[25] Nakamura K, Kitani A, Strober W.  
Cell contact–dependent 
immunosuppression by 
Cd4+Cd25+regulatory T cells is 
mediated by cell surface–bound 
transforming growth factor β. The 
Journal of Experimental Medicine. 
2001;194(5):629-644
[26] Shevach EM. Mechanisms of foxp3+ 
T regulatory cell-mediated suppression. 
Immunity. 2009;30(5):636-645
[27] Thomas DA, Massagué J. TGF-β 
directly targets cytotoxic T cell 
functions during tumor evasion of 
immune surveillance. Cancer Cell. 
2005;8(5):369-380
[28] Trapani JA. The dual adverse 
effects of TGF-beta secretion on 
tumor progression. Cancer Cell. 
2005;8(5):349-350
[29] Yang L, DeBusk LM, Fukuda K, 
Fingleton B, Green-Jarvis B, Shyr Y, 
et al. Expansion of myeloid immune 
suppressor gr+CD11b+ cells in 
tumor-bearing host directly promotes 
tumor angiogenesis. Cancer Cell. 
2004;6(4):409-421
[30] Imai K, Matsuyama S, Miyake S, 
Suga K, Nakachi K. Natural cytotoxic 
activity of peripheral-blood 
lymphocytes and cancer incidence: 
An 11-year follow-up study of 
a general population. Lancet. 
2000;356(9244):1795-1799
[31] Moretta A, Bottino C, Vitale M, 
Pende D, Cantoni C, Mingari MC, et al. 
Activating receptors and coreceptors 
involved in human natural killer cell-
mediated cytolysis. Annual Review of 
Immunology. 2001;19:197-223
Asbestos-Related Diseases
12
[32] Moretta L, Moretta A. Unravelling 
natural killer cell function: Triggering 
and inhibitory human NK receptors. 
The EMBO Journal. 2004;23(2):255-259
[33] Sivori S, Pende D, Bottino C, 
Marcenaro E, Pessino A, Biassoni R, 
et al. NKp46 is the major triggering 
receptor involved in the natural 
cytotoxicity of fresh or cultured 
human NK cells. Correlation between 
surface density of NKp46 and natural 
cytotoxicity against autologous, 
allogeneic or xenogeneic target cells. 
European Journal of Immunology. 
1999;29(5):1656-1666
[34] Yokoyama WM, Plougastel BF.  
Immune functions encoded by 
the natural killer gene complex. 
Nature Reviews. Immunology. 
2003;3(4):304-316
[35] Endt J, Eissmann P, Hoffmann SC, 
Meinke S, Giese T, Watzl C. Modulation 
of 2B4 (CD244) activity and regulated 
SAP expression in human NK cells. 
European Journal of Immunology. 
2007;37(1):193-198
[36] Garni-Wagner BA, Purohit A, 
Mathew PA, Bennett M. Kumar V.  
A novel function-associated molecule 
related to non-MHC-restricted 
cytotoxicity mediated by activated 
natural killer cells and T cells. Journal of 
Immunology. 1993;151(1):60-70
[37] Valiante NM, Trinchieri G.  
Identification of a novel signal 
transduction surface molecule on 
human cytotoxic lymphocytes. The 
Journal of Experimental Medicine. 
1993;178(4):1397-1406
[38] Trapani JA, Smyth MJ. Functional 
significance of the perforin/granzyme 
cell death pathway. Nature Reviews. 
Immunology. 2002;2(10):735-747
[39] Nishimura Y, Miura Y, Maeda M, 
Kumagai N, Murakami S, Hayashi H, 
et al. Impairment in cytotoxicity and 
expression of NK cell- activating 
receptors on human NK cells 
following exposure to asbestos fibers. 
International Journal of 
Immunopathology and Pharmacology. 
2009;22(3):579-590
[40] Chen X, Trivedi PP, Ge B, 
Krzewski K, Strominger JL. Many NK 
cell receptors activate ERK2 and JNK1 
to trigger microtubule organizing 
center and granule polarization 
and cytotoxicity. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
2007;104(15):6329-6334
[41] Nishimura Y, Maeda M, Kumagai N, 
Hayashi H, Miura Y, Otsuki T. Decrease 
in phosphorylation of ERK following 
decreased expression of NK cell-
activating receptors in human NK cell 
line exposed to asbestos. International 
Journal of Immunopathology and 
Pharmacology. 2009;22(4):879-888
[42] Miyoshi I, Kubonishi I, Yoshimoto S. 
Shiraishi Y. A T-cell line derived from 
normal human cord leukocytes by 
co-culturing with human leukemic 
T-cells. Gann. 1981;72(6):978-981
[43] Miyoshi I, Kubonishi I, Yoshimoto S, 
Akagi T, Ohtsuki Y, Shiraishi Y, et al. 
Type C virus particles in a cord 
T-cell line derived by co-cultivating 
normal human cord leukocytes and 
human leukaemic T cells. Nature. 
1981;294(5843):770-771
[44] Maeda M, Nishimura Y, Hayashi H, 
Kumagai N, Chen Y, Murakami S, et al. 
Reduction of CXC chemokine receptor 
3 in an in vitro model of continuous 
exposure to asbestos in a human 
T-cell line, MT-2. American Journal of 
Respiratory Cell and Molecular Biology. 
2011;45(3):470-479
[45] Miura Y, Nishimura Y, 
Katsuyama H, Maeda M, Hayashi H, 
Dong M, et al. Involvement of IL-10 
and Bcl-2 in resistance against an 
13
Suppressed Immune System Caused by Exposure to Asbestos and Malignant Mesothelioma
DOI: http://dx.doi.org/10.5772/intechopen.90763
asbestos-induced apoptosis of T 
cells. Apoptosis: An International 
Journal on Programmed Cell Death. 
2006;11(10):1825-1835
[46] Luster AD, Leder P. IP-10, a -C-X-
C- chemokine, elicits a potent thymus-
dependent antitumor response in vivo. 
The Journal of Experimental Medicine. 
1993;178(3):1057-1065
[47] Sallusto F, Lanzavecchia A. 
Understanding dendritic cell and 
T-lymphocyte traffic through the 
analysis of chemokine receptor 
expression. Immunological Reviews. 
2000;177:134-140
[48] Maeda M, Nishimura Y, Hayashi H, 
Kumagai N, Chen Y, Murakami S, 
et al. Decreased CXCR3 expression 
in CD4+ T cells exposed to Asbestos 
or derived from Asbestos-exposed 
patients. American Journal of 
Respiratory Cell and Molecular Biology. 
2011;45(4):795-803
[49] Sakaguchi S. Naturally arising 
Foxp3-expressing CD25+CD4+ 
regulatory T cells in immunological 
tolerance to self and non-self. Nature 
Immunology. 2005;6(4):345-352
[50] Curotto de Lafaille MA, Lafaille JJ. 
Natural and adaptive foxp3+ regulatory 
T cells: More of the same or a division of 
labor? Immunity. 2009;30(5):626-635
[51] Shimauchi T, Kabashima K,  
Tokura Y. Adult T-cell leukemia/
lymphoma cells from blood and skin 
tumors express cytotoxic T lymphocyte-
associated antigen-4 and Foxp3 but lack 
suppressor activity toward autologous 
CD8+ T cells. Cancer Science. 
2008;99(1):98-106
[52] Matsubar Y, Hori T, Morita R, 
Sakaguchi S, Uchiyama T. Delineation 
of immunoregulatory properties 
of adult T-cell leukemia cells. 
International Journal of Hematology. 
2006;84(1):63-69
[53] Chen S, Ishii N, Ine S, Ikeda S,  
Fujimura T, Ndhlovu LC, et al. 
Regulatory T cell-like activity of Foxp3+ 
adult T cell leukemia cells. International 
Immunology. 2006;18(2):269-277
[54] Kohno T, Yamada Y, Akamatsu N, 
Kamihira S, Imaizumi Y, Tomonaga M, 
et al. Possible origin of adult T-cell 
leukemia/lymphoma cells from human 
T lymphotropic virus type-1-infected 
regulatory T cells. Cancer Science. 
2005;96(8):527-533
[55] Karube K, Ohshima K, Tsuchiya T,  
Yamaguchi T, Kawano R, Suzumiya J,  
et al. Expression of FoxP3, a key 
molecule in CD4CD25 regulatory 
T cells, in adult T-cell leukaemia/
lymphoma cells. British Journal of 
Haematology. 2004;126(1):81-84
[56] Roncador G, Garcia JF, Garcia JF, 
Maestre L, Lucas E, Menarguez J, et al. 
FOXP3, a selective marker for a subset 
of adult T-cell leukaemia/lymphoma. 
Leukemia. 2005;19(12):2247-2253
[57] Vega MI, Huerta-Yepaz S, Garban H, 
Jazirehi A, Emmanouilides C, 
Bonavida B. Rituximab inhibits p38 
MAPK activity in 2F7 B NHL and 
decreases IL-10 transcription: Pivotal 
role of p38 MAPK in drug resistance. 
Oncogene. 2004;23(20):3530-3540
[58] Belkaid Y. Regulatory T cells and 
infection: A dangerous necessity. 
Nature Reviews. Immunology. 
2007;7(11):875-888
[59] McGeachy MJ, Stephens LA,  
Anderton SM. Natural recovery 
and protection from autoimmune 
encephalomyelitis: Contribution of 
CD4+CD25+ regulatory cells within 
the central nervous system. Journal of 
Immunology. 2005;175(5):3025-3032
[60] Serra P, Amrani A, Yamanouchi J, 
Han B, Thiessen S, Utsugi T, et al. CD40 
ligation releases immature dendritic 
cells from the control of regulatory 
Asbestos-Related Diseases
14
CD4+CD25+ T cells. Immunity. 
2003;19(6):877-889
[61] Misra N, Bayry J, Lacroix- 
Desmazes S, Kazatchkine MD, 
Kaveri SV. Cutting edge: Human 
CD4+CD25+ T cells restrain the 
maturation and antigen-presenting 
function of dendritic cells. Journal of 
Immunology. 2004;172(8):4676-4680
[62] Banchereau J, Palucka AK. Dendritic 
cells as therapeutic vaccines against 
cancer. Nature Reviews. Immunology. 
2005;5(4):296-306
[63] Harty JT, Tvinnereim AR, 
White DW. CD8+ T cell effector 
mechanisms in resistance to infection. 
Annual Review of Immunology. 
2000;18:275-308
[64] Catalfamo M, Henkart PA. Perforin 
and the granule exocytosis cytotoxicity 
pathway. Current Opinion in 
Immunology. 2003;15(5):522-527
[65] Allan RS, Waithman J, Bedoui S, 
Jones CM, Villadangos JA, Zhan Y, 
et al. Migratory dendritic cells transfer 
antigen to a lymph node-resident 
dendritic cell population for 
efficient CTL priming. Immunity. 
2006;25(1):153-162
[66] Weninger W, Manjunath N,  
von Andrian UH. Migration 
and differentiation of CD8+ T 
cells. Immunological Reviews. 
2002;186:221-233
[67] Behrens G, Li M, Smith CM, 
Belz GT, Mintern J, Carbone FR, et al. 
Helper T cells, dendritic cells and 
CTL immunity. Immunology and Cell 
Biology. 2004;82(1):84-90
[68] Kumagai-Takei N, Nishimura Y, 
Maeda M, Hayashi H, Matsuzaki H, 
Lee S, et al. Effect of asbestos exposure 
on differentiation of cytotoxic T 
lymphocytes in mixed lymphocyte 
reaction of human peripheral blood 
mononuclear cells. American Journal of 
Respiratory Cell and Molecular Biology. 
2013;49(1):28-36
[69] Fridman WH, Pages F, Sautes- 
Fridman C, Galon J. The immune 
contexture in human tumours: Impact 
on clinical outcome. Nature Reviews 
Cance. 2012;12(4):298-306
[70] Kumagai-Takei N, Nishimura Y,  
Matsuzaki H, Lee S, Yoshitome K, 
Otsuki T. Decrease in intracellular 
Perforin levels and IFN-γ production 
in human CD8+ T cell line following 
long-term exposure to Asbestos fibers. 
Journal of Immunology Research. 
2018;2018:1-10
[71] Kumagai-Takei N, Nishimura Y, 
Maeda M, Hayashi H, Matsuzaki H, 
Lee S, et al. Functional properties 
of CD8(+) lymphocytes in patients 
with pleural plaque and malignant 
mesothelioma. Journal of Immunology 
Research. 2014;2014:670140
[72] Kumagai-Takei N, Nishimura Y,  
Matsuzaki H, Lee S, Yoshitome K,  
Hayashi H, et al. The suppressed 
induction of human mature cytotoxic 
T lymphocytes caused by Asbestos is 
not due to Interleukin-2 insufficiency. 
Journal of Immunology Research. 
2016;2016:10
